The NY Times with a profile. Unsurprisingly, they lack corporate support:
Not surprisingly, Cafepharma lacks corporate fans.
Pfizer, the subject of the site’s most popular bulletin board, declined repeated requests to discuss Cafepharma. Shreya Prudlo, a spokeswoman, said that Pfizer monitored every “communication channel” that reached its constituency, and that each needed to be “viewed based on their accuracy and integrity.”
Medtronic, which has the busiest Cafepharma bulletin board among device makers, said, “We do not endorse sites like this one.” It said it monitored Cafepharma periodically to see if confidential or proprietary information had been posted. Cindy Resman, a spokeswoman, said that Medtronic had not asked Cafepharma to remove any information yet.